Filing Details
- Accession Number:
- 0001179110-13-017684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-10 17:05:39
- Reporting Period:
- 2013-12-06
- Filing Date:
- 2013-12-10
- Accepted Time:
- 2013-12-10 17:05:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1580217 | Jean-Yves Pavee | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2013-12-06 | 5,855 | $25.07 | 36,756 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2013-12-06 | 5,855 | $37.46 | 30,901 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2013-12-06 | 5,855 | $0.00 | 5,855 | $25.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-10-29 | 2014-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares Without Par Value | 1,895 | Indirect | Profit Sharing Trust |
Footnotes
- Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2013.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.